ilShinbioba

At a glance

ilShinbioba filed 22 disclosures in the last 12 months, including 3 contract, 2 insider and 1 5% holder. The most recent key filing was on Oct 2: Worth 6.6% of last year's revenue, over about 6 months.

Revenue for 2025 was ₩14.5B, up 34.3% on 2024. Operating margin was 31.3% against 20.9% a year earlier. Debt was 6% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩6.7B and operating profit of ₩2B.

The 2025 annual report lists 37 employees with an average tenure of 7 years and average pay of ₩57M. Its 4 directors and auditors were paid ₩279M each on average. It paid ₩10 per common share in cash dividends, against ₩7 a year earlier (+42.9%). 홍성대 and related parties held 30.93% at year end.

Of 1 recent 5%+ holder report, 1 raised and 0 cut a stake; the largest stake reported was 32.15% on Jun 4.

From the 2025 annual report

Staff: 37 (33 men, 4 women), of whom 3 on fixed-term contracts. Total pay for the year: ₩2.1B. Directors and auditors: 4, paid ₩1.1B in total.

Dividends (common shares)

Largest shareholder

홍성대 holds 29.63%; with 4 related parties the group holds 30.93% of common shares at year end (from 30.66% at the start of the year).

Individuals paid ₩500M or more

Auditor: 이촌회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

New contracts, last 12 months

3 new supply contracts worth 52% of the revenue stated in the filings.

Amended amounts replace the originals. Subsidiary contracts and terminations are excluded.

Financial summary

5%+ holder reports